$AMAT

Iannotti Thomas J sold $5.5M of AMAT

Iannotti Thomas J sold 9,250 shares of APPLIED MATERIALS INC /DE (AMAT) at $599.77 ($5.55M total) on 2026-06-16.

Original reporting
SEC EDGAR · Iannotti Thomas J
Published Jun 17, 2026, 10:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMAT
Neutral
high confidence
Mentioned
$AMAT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMATNeutralLow
01

Why it matters

The disclosure updates ownership/transaction details for a director but does not introduce new operational or financial information about AMAT.

02

Market read

Traders may note the sale, but without accompanying fundamental catalysts it is unlikely to drive sustained repricing.

03

What to watch

The article provides no context on prior sales, total compensation, or whether the sale was part of routine liquidity needs, limiting trading usefulness.

Relevance 6/10Novelty 4/10Timing: Filed 2026-06-17; transaction dated 2026-06-16.

Background

This is an SEC Form 4 insider transaction disclosure for Applied Materials (AMAT).

Company-level read

Ticker impact

$AMATNeutralHigh confidence
Context

Applied Materials disclosed an insider open-market sale by director Thomas J. Iannotti of 9,250 shares at $599.77 on 2026-06-16.

Expected impact

Low near-term impact; any effect is likely muted and short-lived.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it is not tied to new company fundamentals, guidance, or regulatory/contract events.

Market effects

No direct read-across to semiconductor equipment demand or industry conditions from this single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification/taxes and may not reflect bearish views; the absence of a 10b5-1 plan further reduces interpretability.

Key entities

  • Applied Materials, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Thomas J. Iannotti

    Director who sold 9,250 shares in an open-market sale on 2026-06-16.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

$AMATMed

Applied Materials Targets AI-Led Market Share Gains and Higher Margins by 2030

Applied Materials (AMAT) expects to gain market share in wafer-fab equipment, leading-edge logic, DRAM, and advanced packaging by 2030. The company anticipates revenue growth in process control and services, with AIx platform improving yield and factory output. Financial targets include $12B+ in services revenue and 54% gross margin by 2030. AMAT plans to return 80-100% of free cash flow to shareholders.

$AMATHighAI 8/10

Why Applied Materials Sank Today

Applied Materials (AMAT) shares fell 7.2% after an investor presentation lacked revenue growth projections. The company forecast 2030 margins of 54% gross and 40% operating, with services revenue exceeding $12B. Investors reacted negatively to the absence of overall revenue guidance, despite bullish long-term outlooks on AI-driven growth.

$JPMHighAI 8/10

Wall Street Lunch: Bank Earnings Nothing To Write Home About (undefined:JPM)

JPMorgan Chase (JPM) missed Q3 earnings estimates, with Fixed Income & Markets revenue falling 4% Y/Y. Goldman Sachs (GS) beat estimates, while Wells Fargo (WFC) and Citigroup (C) showed mixed results. UnitedHealth Group (UNH) raised its full-year outlook, and Johnson & Johnson (JNJ) reported a Q3 beat but saw shares weighed down by MedTech revenue. Applied Materials (AMAT) declined post-investor presentation. Fund managers increased tech sector exposure to a six-year high.